Genetic Signatures Limited (ASX: GSS)
Australia
· Delayed Price · Currency is AUD 0.650
-0.030 (-4.41%)
Dec 4, 2024, 3:41 PM AEST
Genetic Signatures Company Description
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa.
It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name.
The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens.
In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease.
The company was incorporated in 2001 and is headquartered in Newtown, Australia.
Genetic Signatures Limited
| Country | Australia |
| Founded | 2001 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Allison Rossiter |
Contact Details
Address: Heart Research Institute Newtown Australia | |
| Phone | 61 2 9870 7580 |
Stock Details
| Ticker Symbol | GSS |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000GSS4 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Allison Rossiter | Chief Executive Officer |
| Karl David Pechmann | Chief Financial Officer, Chief Operating Officer and Company Secretary |
| Michael Anton Aicher BSc, M.B.A., MBA | Executive Director of US Operations and Executive Director |
| Christopher M. Abbott A.M., AM, F.C.A., FCA, Ph.D., Ph.D., (Hon) | Founder and Chairman Emeritus |
| Rebecca Abbatantuono | Global Head of People and Culture |
| Neralie Coulston B.Sc. | Global Head of Regulatory Affairs |
| Rohan Baker | Head of Research and Acting QC Manager |